Analysts Are Bullish on These Healthcare Stocks: MiMedx Group (MDXG), Ufp Technologies (UFPT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on MiMedx Group (MDXG – Research Report), Ufp Technologies (UFPT – Research Report) and Travere Therapeutics (TVTX – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MiMedx Group (MDXG)
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on MiMedx Group. The company’s shares closed last Monday at $5.19.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of
MiMedx Group has an analyst consensus of Strong Buy, with a price target consensus of $9.60, representing an 82.5% upside. In a report released today, Citizens JMP also initiated coverage with a Buy rating on the stock with a $10.00 price target.
See today’s best-performing stocks on TipRanks >>
Ufp Technologies (UFPT)
Lake Street analyst Max Michaelis maintained a Buy rating on Ufp Technologies today. The company’s shares closed last Monday at $232.68.
According to TipRanks.com, Michaelis is a 5-star analyst with an average return of
The the analyst consensus on Ufp Technologies is currently a Moderate Buy rating.
Travere Therapeutics (TVTX)
In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on Travere Therapeutics. The company’s shares closed last Monday at $29.78.
According to TipRanks.com, Rama is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Travere Therapeutics with a $42.73 average price target, which is a 43.2% upside from current levels. In a report issued on February 20, TipRanks – Google also upgraded the stock to Buy with a $33.00 price target.
